Cancer Research Annual Meeting 2010  Jordan
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Cancer Research 68, 10223, December 15, 2008. doi: 10.1158/0008-5472.CAN-08-1833
© 2008 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by DeBusk, L. M.
Right arrow Articles by Lin, P. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by DeBusk, L. M.
Right arrow Articles by Lin, P. C.

Experimental Therapeutics, Molecular Targets, and Chemical Biology

I{kappa}B Kinase-{alpha} Regulates Endothelial Cell Motility and Tumor Angiogenesis

Laura M. DeBusk1, Pierre P. Massion1,2 and P. Charles Lin1,3,4

Departments of 1 Cancer Biology, 2 Medicine, 3 Radiation Oncology, and 4 Cell and Development Biology, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee

Requests for reprints: P. Charles Lin, Vanderbilt University Medical Center, 712 PRB, 2220 Pierce Avenue, Nashville, TN 37232. Phone: 615-936-1749; Fax: 615-936-1872; E-mail: Charles.lin{at}vanderbilt.edu.

Key Words: angiogenesis • endothelial cell • IKK{alpha} • NF-{kappa}B • tumor

The transcription factor nuclear factor-{kappa}B (NF-{kappa}B) is constitutively activated in many types of cancers and has been implicated in gene expression important for angiogenesis, tumor growth, progression, and metastasis. Here, we show that the NF-{kappa}B activator, I{kappa}B kinase-{alpha} (IKK{alpha}), but not IKKβ, promotes endothelial cell motility and tumor angiogenesis. IKK{alpha} is elevated in tumor vasculature compared with normal endothelium. Overexpression of IKK{alpha} in endothelial cells promoted cell motility and vascular tubule formation in a three-dimensional culture assay, and conversely, knockdown of IKK{alpha} in endothelial cells inhibited cell motility, compared with controls. Interestingly, blocking NF-{kappa}B activation totally abolished IKK{alpha}-induced angiogenic function. Furthermore, using a tumor and endothelial cell cotransplantation model, we show that overexpression of IKK{alpha} in endothelial cells significantly increased tumor vascular formation compared with controls, which contributed to increased tumor growth and tumor cell proliferation, and decreased tumor cell apoptosis. Collectively, these findings have identified a new function for IKK{alpha} through the canonical NF-{kappa}B pathway in tumor angiogenesis. [Cancer Res 2008;68(24):10223–8]




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
J. M. Warfel and F. D'Agnillo
Anthrax Lethal Toxin Enhances I{kappa}B Kinase Activation and Differentially Regulates Pro-inflammatory Genes in Human Endothelium
J. Biol. Chem., September 18, 2009; 284(38): 25761 - 25771.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2008 by the American Association for Cancer Research.